|

COPD Clinical Trials in New York, NY

21 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3<1 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Phase 3<1 mi
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.N/A<1 mi
Evaluation Of The Lung Microbiome In NTM Bronchiectasis—<1 mi
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the HospitalN/A<1 mi
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-managementN/A<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDPhase 2<1 mi
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies—<1 mi
Lung Microbiome and Inflammation in Early COPD—<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)—<1 mi
PiMZ Longitudinal Cohort (PiMZ Logic)—<1 mi
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDPhase 25 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePhase 311 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Phase 313 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)Phase 217 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening—34 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePhase 335 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPDPhase 235 mi
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Phase 337 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePhase 237 mi
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)Phase 248 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.